--- title: "IMMUDEX ApS – CVR 31348854, regnskab og ejerforhold" description: "IMMUDEX ApS (CVR 31348854). Aktiv · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik · Virum. 37 ansatte (CVR). Bruttofortjeneste 22,7 mio. DKK (2025)." canonical_url: "https://datapublica.dk/companies/31348854-immudex-aps" locale: "da" route_type: "company_overview" robots: "index,follow" --- # IMMUDEX ApS IMMUDEX ApS \(CVR 31348854\). Aktiv · Forskning og eksperimentel udvikling inden for naturvidenskab og teknik · Virum. 37 ansatte \(CVR\). Bruttofortjeneste 22,7 mio. DKK \(2025\). CVR-nummer: 31348854 ## Virksomhedsoplysninger - **CVR-nummer:** 31348854 - **Status:** Aktiv - **Adresse:** Bredevej 2A, 2830, Virum - **Virksomhedsform:** Anpartsselskab \(ApS\) - **Stiftet:** 1. apr. 2008 - **Antal ansatte \(CVR\):** 37 - **Produktionsenheder:** 1 - **Website:** https://www.immudex.com/ ## Beskrivelse Description of key activities of the companyThe main activities of Immudex are to provide MHC Dextramer® reagents and services for improved cellular immune monitoring to be used in research, clinical development and patient monitoring. The Company has during the fiscal year had the following focus areas: i. Increase sales of clinical-grade Dextramer \(GMP\) reagents to biophama companies engaged in T-cell therapy development ii. Increase output of new products and services by investing in more R&D activities, and we launched several new products in the year iii. Expand commercial activities The year was another difficult year as many of our biopharma companies experienced slow down in their pipelines due to lack of financing. We saw therefore a low increase in sales. Immudex continued to invest significant resources in 1\) the development of new Dextramer® reagents, 2\) in expanding commercial activities 3\) maintaining and protecting existing patent portfolio. In the next financial year, a continued expansion of Immudex’ product portfolio will take place. Immudex is entering new clinical application areas, such as CAR-T, Autoimmunity, to continue to expand the available markets for the company. ## Aktiviteter og branche - Forskning og eksperimentel udvikling inden for naturvidenskab og teknik - 721000 — Forskning og eksperimentel udvikling inden for naturvidenskab og teknik ## Seneste regnskabsperiode - **Regnskabsperiode:** 2024/25 \(1. jul. 2024 - 30. jun. 2025\) - **Valuta:** DKK - **Bruttofortjeneste:** 22.665.406 - **Driftsresultat:** -10.987.916 - **Årets resultat:** -11.025.449 - **Aktiver:** 49.096.111 - **Egenkapital:** 16.050.190 ## Ledelse og roller | Person | Roller | Titler | | --- | --- | --- | | [Hans Christian Barré Pedersen](https://datapublica.dk/people/pid_entity_4010275223-hans-christian-barr-pedersen) | Bestyrelse | BESTYRELSESMEDLEM | | [Jamil El-Ali](https://datapublica.dk/people/pid_entity_4010583264-jamil-el-ali) | Bestyrelse | BESTYRELSESMEDLEM | | [Søren Elmann Ingerslev](https://datapublica.dk/people/pid_entity_4004097184-s-ren-elmann-ingerslev) | Bestyrelse | FORMAND | | [Patrik Olof Dahlén](https://datapublica.dk/people/pid_entity_4004071902-patrik-olof-dahl-n) | Direktion | ADM. DIR. | ## Revisor | Revisionsfirma | Revisor | Rolle | Fra | | --- | --- | --- | --- | | Powered-By, Statsautoriseret Revisionspartnerselskab | Søren Strandby | statsautoriseret revisor | 13. nov. 2025 | ## Kontakt ### Fra [cvr.dk](https://datacvr.virk.dk/) | Kontakt | Telefon | Email | | --- | --- | --- | | Virksomhed | 3110\*\*\*\* [Vis hele](https://datapublica.dk/signup?redirectTo=%2Fcompanies%2F31348854-immudex-aps) | \*\*@immudex.com [Vis hele](https://datapublica.dk/signup?redirectTo=%2Fcompanies%2F31348854-immudex-aps) | Afdelinger \(1\) IMMUDEX ApS · Bredevej 2A · P-1014323844 | Kontakt | Telefon | Email | | --- | --- | --- | | Virksomhed | 3110\*\*\*\* [Vis hele](https://datapublica.dk/signup?redirectTo=%2Fcompanies%2F31348854-immudex-aps) | h\*\*@immudex.com [Vis hele](https://datapublica.dk/signup?redirectTo=%2Fcompanies%2F31348854-immudex-aps) | ## Legale ejere ### Aktuelle | Ejer | Ejerandel | Stemmeandel | Fra | | --- | --- | --- | --- | | EjerVIGGO HARBOE 2006 HOLDING ApS | Ejerandel50–66,66 % | Stemmeandel50 % | Fra6. feb. 2017 | | EjerGUNNERSEN MARKER HOLDING ApS | Ejerandel20–24,99 % | Stemmeandel20 % | Fra18. jun. 2020 | | EjerHJECA HOLDING I ApS | Ejerandel5–9,99 % | Stemmeandel5 % | Fra14. feb. 2017 | ### Tidligere | Ejer | Ejerandel | Stemmeandel | Fra | Til | | --- | --- | --- | --- | --- | | EjerGUNNERSEN MARKER HOLDING ApS | Ejerandel25–33,32 % | Stemmeandel25 % | Fra14. nov. 2014 | Til17. jun. 2020 | | EjerCHEMGENE ApS | Ejerandel10–14,99 % | Stemmeandel10 % | Fra9. nov. 2015 | Til6. feb. 2017 | | EjerVIGGO HARBOE 2006 HOLDING ApS | Ejerandel33,33–49,99 % | Stemmeandel33,33 % | Fra9. nov. 2015 | Til5. feb. 2017 | | EjerHJECA HOLDING I ApS | Ejerandel5–9,99 % | Stemmeandel5 % | Fra16. okt. 2015 | Til8. nov. 2015 | | EjerCHEMGENE ApS | Ejerandel15–19,99 % | Stemmeandel15 % | Fra5. dec. 2014 | Til8. nov. 2015 | | EjerVIGGO HARBOE 2006 HOLDING ApS | Ejerandel25–33,32 % | Stemmeandel25 % | Fra14. nov. 2014 | Til8. nov. 2015 | ## Ultimative ejere [Se ejerdiagram](https://datapublica.dk/companies/31348854-immudex-aps/portfolio) | Navn | Ejerskab gennem | Beregnet ejerandel | | --- | --- | --- | | Viggo Gunnersen Harboe | VIGGO HARBOE 2006 HOLDING ApS | 50–66,66 % | | Helene Kähler Hjenner | HJECA HOLDING I ApS | 5–9,99 % | | Emil Peter Skov Marker | GUNNERSEN MARKER HOLDING ApS | 3–5 % | | Julie Bacher Marker | GUNNERSEN MARKER HOLDING ApS | 3–5 % | | Lucas Peter Skov Marker | GUNNERSEN MARKER HOLDING ApS | 3–5 % | | Marie Bacher Marker | GUNNERSEN MARKER HOLDING ApS | 3–5 % | | Rosemarie Ida Skov Marker | GUNNERSEN MARKER HOLDING ApS | 3–5 % | | Sarah Bacher Marker | GUNNERSEN MARKER HOLDING ApS | 3–5 % | | Anders Johannes Skov Marker | Marskov Holding ApS → FORCE INVEST ApS → GUNNERSEN MARKER HOLDING ApS | 1–2,5 % | | Morten Kofoed Marker | Karmo Holding ApS → FORCE INVEST ApS → GUNNERSEN MARKER HOLDING ApS | 1–2,5 % | ## Virksomhedssider - [Overblik](https://datapublica.dk/companies/31348854-immudex-aps) - [Regnskab](https://datapublica.dk/companies/31348854-immudex-aps/financials) - [Risiko](https://datapublica.dk/companies/31348854-immudex-aps/risk) - [Tidslinje](https://datapublica.dk/companies/31348854-immudex-aps/timeline) - [Ejerskab og relationer](https://datapublica.dk/companies/31348854-immudex-aps/portfolio) - [Produktionsenheder](https://datapublica.dk/companies/31348854-immudex-aps/production-units) - [Gazelle](https://datapublica.dk/companies/31348854-immudex-aps/gazelle) - [Investeringer](https://datapublica.dk/companies/31348854-immudex-aps/investments) - [Virksomhedens hjemmeside](https://www.immudex.com/) ## Officielle kilder - [Officiel CVR-post hos Virk](https://datacvr.virk.dk/enhed/virksomhed/31348854)